2023-12-112024-12-312024-12-31false15343350ROUTE 999 MEDICAL SERVICES LTD2025-06-18falseiso4217:GBPxbrli:pure153433502023-12-11153433502024-12-31153433502023-12-112024-12-31153433502023-12-10153433502023-12-10153433502023-12-102023-12-1015343350bus:SmallEntities2023-12-112024-12-3115343350bus:AuditExempt-NoAccountantsReport2023-12-112024-12-3115343350bus:FullAccounts2023-12-112024-12-3115343350bus:PrivateLimitedCompanyLtd2023-12-112024-12-3115343350core:WithinOneYear2024-12-3115343350core:AfterOneYear2024-12-3115343350core:WithinOneYear2023-12-1015343350core:AfterOneYear2023-12-1015343350core:ShareCapital2024-12-3115343350core:SharePremium2024-12-3115343350core:RevaluationReserve2024-12-3115343350core:OtherReservesSubtotal2024-12-3115343350core:RetainedEarningsAccumulatedLosses2024-12-3115343350core:ShareCapital2023-12-1015343350core:SharePremium2023-12-1015343350core:RevaluationReserve2023-12-1015343350core:OtherReservesSubtotal2023-12-1015343350core:RetainedEarningsAccumulatedLosses2023-12-1015343350core:LandBuildings2024-12-3115343350core:PlantMachinery2024-12-3115343350core:Vehicles2024-12-3115343350core:FurnitureFittings2024-12-3115343350core:OfficeEquipment2024-12-3115343350core:NetGoodwill2024-12-3115343350core:IntangibleAssetsOtherThanGoodwill2024-12-3115343350core:ListedExchangeTraded2024-12-3115343350core:UnlistedNon-exchangeTraded2024-12-3115343350core:LandBuildings2023-12-1015343350core:PlantMachinery2023-12-1015343350core:Vehicles2023-12-1015343350core:FurnitureFittings2023-12-1015343350core:OfficeEquipment2023-12-1015343350core:NetGoodwill2023-12-1015343350core:IntangibleAssetsOtherThanGoodwill2023-12-1015343350core:ListedExchangeTraded2023-12-1015343350core:UnlistedNon-exchangeTraded2023-12-1015343350core:LandBuildings2023-12-112024-12-3115343350core:PlantMachinery2023-12-112024-12-3115343350core:Vehicles2023-12-112024-12-3115343350core:FurnitureFittings2023-12-112024-12-3115343350core:OfficeEquipment2023-12-112024-12-3115343350core:NetGoodwill2023-12-112024-12-3115343350core:IntangibleAssetsOtherThanGoodwill2023-12-112024-12-3115343350core:ListedExchangeTraded2023-12-112024-12-3115343350core:UnlistedNon-exchangeTraded2023-12-112024-12-3115343350core:MoreThanFiveYears2023-12-112024-12-3115343350core:Non-currentFinancialInstruments2024-12-3115343350core:Non-currentFinancialInstruments2023-12-1015343350dpl:CostSales2023-12-112024-12-3115343350dpl:DistributionCosts2023-12-112024-12-3115343350core:LandBuildings2023-12-112024-12-3115343350core:PlantMachinery2023-12-112024-12-3115343350core:Vehicles2023-12-112024-12-3115343350core:FurnitureFittings2023-12-112024-12-3115343350core:OfficeEquipment2023-12-112024-12-3115343350dpl:AdministrativeExpenses2023-12-112024-12-3115343350core:NetGoodwill2023-12-112024-12-3115343350core:IntangibleAssetsOtherThanGoodwill2023-12-112024-12-3115343350dpl:GroupUndertakings2023-12-112024-12-3115343350dpl:ParticipatingInterests2023-12-112024-12-3115343350dpl:GroupUndertakingscore:ListedExchangeTraded2023-12-112024-12-3115343350core:ListedExchangeTraded2023-12-112024-12-3115343350dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-12-112024-12-3115343350core:UnlistedNon-exchangeTraded2023-12-112024-12-3115343350dpl:CostSales2023-12-102023-12-1015343350dpl:DistributionCosts2023-12-102023-12-1015343350core:LandBuildings2023-12-102023-12-1015343350core:PlantMachinery2023-12-102023-12-1015343350core:Vehicles2023-12-102023-12-1015343350core:FurnitureFittings2023-12-102023-12-1015343350core:OfficeEquipment2023-12-102023-12-1015343350dpl:AdministrativeExpenses2023-12-102023-12-1015343350core:NetGoodwill2023-12-102023-12-1015343350core:IntangibleAssetsOtherThanGoodwill2023-12-102023-12-1015343350dpl:GroupUndertakings2023-12-102023-12-1015343350dpl:ParticipatingInterests2023-12-102023-12-1015343350dpl:GroupUndertakingscore:ListedExchangeTraded2023-12-102023-12-1015343350core:ListedExchangeTraded2023-12-102023-12-1015343350dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-12-102023-12-1015343350core:UnlistedNon-exchangeTraded2023-12-102023-12-1015343350core:NetGoodwill2024-12-3115343350core:IntangibleAssetsOtherThanGoodwill2024-12-3115343350core:LandBuildings2024-12-3115343350core:PlantMachinery2024-12-3115343350core:Vehicles2024-12-3115343350core:FurnitureFittings2024-12-3115343350core:OfficeEquipment2024-12-3115343350core:AfterOneYear2024-12-3115343350core:WithinOneYear2024-12-3115343350core:ListedExchangeTraded2024-12-3115343350core:UnlistedNon-exchangeTraded2024-12-3115343350core:ShareCapital2024-12-3115343350core:SharePremium2024-12-3115343350core:RevaluationReserve2024-12-3115343350core:OtherReservesSubtotal2024-12-3115343350core:RetainedEarningsAccumulatedLosses2024-12-3115343350core:NetGoodwill2023-12-1015343350core:IntangibleAssetsOtherThanGoodwill2023-12-1015343350core:LandBuildings2023-12-1015343350core:PlantMachinery2023-12-1015343350core:Vehicles2023-12-1015343350core:FurnitureFittings2023-12-1015343350core:OfficeEquipment2023-12-1015343350core:AfterOneYear2023-12-1015343350core:WithinOneYear2023-12-1015343350core:ListedExchangeTraded2023-12-1015343350core:UnlistedNon-exchangeTraded2023-12-1015343350core:ShareCapital2023-12-1015343350core:SharePremium2023-12-1015343350core:RevaluationReserve2023-12-1015343350core:OtherReservesSubtotal2023-12-1015343350core:RetainedEarningsAccumulatedLosses2023-12-1015343350core:NetGoodwill2023-12-1015343350core:IntangibleAssetsOtherThanGoodwill2023-12-1015343350core:LandBuildings2023-12-1015343350core:PlantMachinery2023-12-1015343350core:Vehicles2023-12-1015343350core:FurnitureFittings2023-12-1015343350core:OfficeEquipment2023-12-1015343350core:AfterOneYear2023-12-1015343350core:WithinOneYear2023-12-1015343350core:ListedExchangeTraded2023-12-1015343350core:UnlistedNon-exchangeTraded2023-12-1015343350core:ShareCapital2023-12-1015343350core:SharePremium2023-12-1015343350core:RevaluationReserve2023-12-1015343350core:OtherReservesSubtotal2023-12-1015343350core:RetainedEarningsAccumulatedLosses2023-12-1015343350core:AfterOneYear2023-12-112024-12-3115343350core:WithinOneYear2023-12-112024-12-3115343350core:Non-currentFinancialInstrumentscore:CostValuation2023-12-112024-12-3115343350core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-112024-12-3115343350core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-112024-12-3115343350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-112024-12-3115343350core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-112024-12-3115343350core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-112024-12-3115343350core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-112024-12-3115343350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-112024-12-3115343350core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-112024-12-3115343350core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3115343350core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3115343350core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3115343350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3115343350core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3115343350core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3115343350core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3115343350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3115343350core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3115343350core:Non-currentFinancialInstrumentscore:CostValuation2023-12-1015343350core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-1015343350core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-1015343350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-1015343350core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-1015343350core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-1015343350core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-1015343350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-1015343350core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-1015343350bus:Director12023-12-112024-12-31

ROUTE 999 MEDICAL SERVICES LTD

Registered Number
15343350
(England and Wales)

Unaudited Financial Statements for the Period ended
31 December 2024

ROUTE 999 MEDICAL SERVICES LTD
Company Information
for the period from 11 December 2023 to 31 December 2024

Director

SMITH, Megan Louise

Registered Address

20 Sedbergh Close Sedbergh Close
Nottingham
NG13 8ZG

Registered Number

15343350 (England and Wales)
ROUTE 999 MEDICAL SERVICES LTD
Balance Sheet as at
31 December 2024

Notes

2024

£

£

Fixed assets
Intangible assets310,800
Tangible assets44,044
14,844
Current assets
Debtors51,870
1,870
Creditors amounts falling due within one year6(18,608)
Net current assets (liabilities)(16,738)
Total assets less current liabilities(1,894)
Net assets(1,894)
Capital and reserves
Called up share capital1
Profit and loss account(1,895)
Shareholders' funds(1,894)
The financial statements were approved and authorised for issue by the Director on 18 June 2025, and are signed on its behalf by:
SMITH, Megan Louise
Director
Registered Company No. 15343350
ROUTE 999 MEDICAL SERVICES LTD
Notes to the Financial Statements
for the period ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Goodwill
Goodwill arising on an acquisition of a business is carried at cost less accumulated impairment losses, if any. Goodwill is amortised over its expected useful life which is estimated to be ten years. Goodwill is assessed for impairment when there are indicators of impairment and any impairment is charged to the income statement. No reversals of impairment are recognised.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Office Equipment25
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

2024
Average number of employees during the year1
3.Intangible assets

Goodwill

Total

££
Cost or valuation
Additions12,00012,000
At 31 December 2412,00012,000
Amortisation and impairment
Charge for year1,2001,200
At 31 December 241,2001,200
Net book value
At 31 December 2410,80010,800
At 10 December 23--
4.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
Additions4,7354,735
At 31 December 244,7354,735
Depreciation and impairment
Charge for year691691
At 31 December 24691691
Net book value
At 31 December 244,0444,044
At 10 December 23--
5.Debtors: amounts due within one year

2024

£
Trade debtors / trade receivables1,870
Total1,870
6.Creditors: amounts due within one year

2024

£
Amounts owed to related parties17,883
Accrued liabilities and deferred income725
Total18,608
7.Related party transactions
During the year interest free loans were made available to the business by directors of £17,883.